Panta rhei, also drug eluting stent technology

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Biomaterials Science

Background:

• The Resolute zotarolimus eluting stent (ZES) is a next-generation durable polymer, thin-strut drug-eluting stent.
• While previous studies confirmed its safety and efficacy, long-term follow-up data remain limited.

Discussion:

• This prospective, multicenter, single-arm study evaluated the 5-year clinical performance of Resolute ZES.
• The findings indicate a favorable long-term safety and efficacy profile for the Resolute ZES.

Key Insights:

• Resolute ZES implantation was associated with a considerably low rate of target lesion revascularization over 5 years.
• The incidence of stent thrombosis remained low at the 5-year follow-up.
• These results support the durability and reliability of next-generation drug-eluting stents.

Outlook:

• Long-term performance data for next-generation drug-eluting stents are essential for informed clinical practice.
• Further research should continue to monitor outcomes of Resolute ZES and similar devices.
• These findings contribute to the evidence base for contemporary interventional cardiology procedures.